9th Pharmaron Symposium on Synthetic and Medicinal Chemistry
Capabilities
September 21, 2019 l Beijing Headquarters
Pharmaron held its 9th Symposium on Synthetic and Medicinal Chemistry which included eight world-renowned professors and industry leaders from US, Europe and China. Presenters discussed latest advancements in synthetic and medicinal chemistry, which included newly developed synthetic methodologies, total synthesis of highly complex natural products, design and synthesis of biologically active molecules, and the philosophy as a chemist.
- Dr. Kevin Campos, MSD, USA
Innovations in Synthetic Chemistry at MSD: Striving for the Ideal Commercial Manufacturing Process - Dr. Werngard Czechtizky, AstraZeneca, Sweden
Leveraging New Modalities for Respiratory:The Exciting Chemical Space between Small Molecules & Antibodies - Prof. Francois Diederich, ETH Zurich, Switzerland
Molecular Recognition in Chemical and Biological Systems: Chemical Models and Biostructural Investigations - Dr. Michael Hahn, Bayer AG, Germany
Discovery of a Novel Oral NO- and Heme-Independent sGC Activator BAY 1101042 - Dr. Bayard R. Huck, Merck KGaA, Germany
It’s a Small-Molecule World: Medicinal Chemistry Challenges and Opportunities for the Next Decade - Prof. Guosheng Liu, Shanghai Institute of Organic Chemistry, China
Copper-Catalyzed Radical Relay for Asymmetric C-H Functionalization - Prof. David MacMillan, Princeton University, USA
New Photoredox Reactions for Medicinal Chemistry and Biological - Dr. Jan Willem Thuring, Janssen Pharmaceutica Research & Development, BelgiumDiscovery of JNJ-64619178 as a Potent and Selective PRMT5 Inhibitor for the Treatment of Lung and Hematologic Cancers